The challenge of pituitary hyperplasia differential diagnosis in a young girl with growth arrest
Abstract
Growth arrest is an alarming condition which requires precise and tempestive investigations in order to provide accurate diagnosis. Long-standing primary hypothyroidism (PHT) may rarely occur as a growth arrest as the only clinical sign at onset in children. The most common cause of PHT in children and adolescents is represented by Hashimoto’s thyroiditis (HT), an autoimmune disease which frequently presents clinically with goitre. Rarely, HT may present as an atrophic variant without goitre, which may delay the diagnosis of PHT. Long-standing PHT is an unusual cause of pituitary hyperplasia (PH) and it has to be differentiated from severe conditions, including neoplasms. Loss of thyroxine feedback determines overproduction of thyrotropin releasing hormone, thyrotropin (TSH)-releasing cells hyperplasia and a consequent pituitary enlargement. Levothyroxine replacement therapy usually determines regression of PH. This report describes a case of an 11-year-old girl suffering from PHT and secondary PH due to autoimmune atrophic thyroiditis whose only onset symptom was growth arrest.
Thyroid hormone evaluation should be included in the first step of evaluations in patients with growth arrest even in the absence of clear clinical signs suggestive of thyroid disfunction. In patients with pituitary enlargement, thyroid function tests are important to recognize PH secondary to PHT and to avoid unnecessary surgery.
Keywords
Full Text:
PDFReferences
1. de Vries, L., Bulvik, S., Phillip, M. (2009). Chronic autoimmune thyroiditis in children and adolescents: at presentation and during long-term follow-up. Arch Dis Child, 94(1), 33-7. doi: 10.1136/adc.2007.134841.
2. Cao, J., Lei, T., Chen, F., Zhang, C., Ma, C., Huang, H. (2018) Primary hypothyroidism in a child leads to pituitary hyperplasia: A case report and literature review. Medicine (Baltimore). 97(42), e12703. doi: 10.1097/MD.0000000000012703.
3. Sapkota, S., Karn, M., Sapkota, S. (2021). Pituitary hyperplasia in childhood primary hypothyroidism: a review. Childs Nerv Syst. 37(3), 749-762. doi: 10.1007/s00381-020-05014-6.
4. de Onis, M., Onyango, A.W., Borghi, E., Siyam, A., Nishida, C., Siekmann, J. (2007) Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 85(9), 660-7. doi: 10.2471/blt.07.043497.
5. Crisafulli, G., Aversa, T., Zirilli, G., Pajno, G.B., Corica, D., De Luca, F. et al. (2019) Subclinical Hypothyroidism in Children: When a Replacement Hormonal Treatment Might Be Advisable. Front Endocrinol (Lausanne). 10, 109. doi: 10.3389/fendo.2019.00109.
6. De Luca, F., Santucci, S., Corica, D., Pitrolo, E., Romeo, M., Aversa, T. (2013) Hashimoto's thyroiditis in childhood: presentation modes and evolution over time. Ital J Pediatr. 39, 8. doi: 10.1186/1824-7288-39-8.
7. Wasniewska, M., Corrias, A., Salerno, M., Mussa, A., Capalbo, D., Messina, M.F., et al. (2012). Thyroid function patterns at Hashimoto's thyroiditis presentation in childhood and adolescence are mainly conditioned by patients' age. Horm Res Paediatr. 78, 232-236. doi: 10.1159/000343815.
8. Matsuura, N., Konishi, J., Yuri, K., Harada, S., Fujieda, K., Nohara, Y., Mikami, Y., Kasagi, K., Iida, Y., Hosoda, A., et al. (1990). Comparison of atrophic and goitrous auto-immune thyroiditis in children: clinical, laboratory and TSH-receptor antibody studies. European Journal of Pediatrics. 149(8), 529-533. doi: 10.1007/BF01957685.
9. Beck-Peccoz, P., Brucker-Davis, F., Persani, L., Smallridge, R.C., Weintraub, B.D. (1996). Thyrotropin-secreting pituitary tumors. Endocrine Rev. 17, 610-638. doi 10.1210/edrv-17-6-610.
10. Khawaja, N.M., Taher, B.M., Barham, M.E., Naser, A.A., Hadidy, A.M., Ahmad, A.T., et al. (2006). Pituitary enlargement in patients with primary hypothyroidism. Endocr Pract.12, 29-34. doi: 10.4158/EP.12.1.29.
11. Vidal, S., Horvath, E., Kovacs, K., Cohen, S.M., Lloyd, R.V., Scheithauer, B.W. (2000). Transdifferentiation of somatotrophs to thyrotrophs in the pituitary of patients with protracted primary hypothyroidism. Virchows Arch. 436(1), 43-51. doi: 10.1007/pl0000819.
12. Radiana, S., Coculescua, M., Morriss, J.F. (2003). Somatotroph to thyrotroph cell trans differentiation during experimental hypothyroidism- a light and electron-microscopy study. J Cell Mol Med. 7, 297-306. doi:10.1111/j.1582-4934.2003.tb00230.x.
13. Kim, K., Arai, K., Sanno, N., Teramoto, A., Shibasaki, T. (2001). The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas. Clin Endocrinol (Oxf). 54, 309-16. doi: 10.1046/j.1365-2265.2001.01237.x.
14. Bruhn, T.O., Rondeel, J.M., Bolduc, T.G., Jackson, I.M. (1994). Thyrotropin-releasing hormone (TRH) gene expression in the anterior pituitary. I. Presence of pro-TRH messenger ribonucleic acid and pro-TRH-derived peptide in a subpopulation of somatotrophs. Endocrinology. 134(2), 815-820 doi: 10.1210/endo.134.2.8299576.
15. Cox, T.D., Estler, A.D. (1991) Normal pituitary gland: changes in shape, size and signal intensity during the first year of life at MR imaging. Radiology. 179, 721-724. doi: 10.1148/radiology.179.3.2027981.
16. Elster, A.D., Chen, M.Y.M., Williams, D.W. III, Key, L.L. (1990). Pituitary gland: MR imaging of physiologic hypertrophy in adolescence. Radiology. 174, 681-685. doi: 10.1148/radiology.174.3.2305049.
Connor, S.E., Penney, C.C. (2003). MRI in the differential diagnosis of a sellar mass. Clin Radiol. 58(1), 20-31. doi: 10.1053/crad.2002.1119.
DOI: https://doi.org/10.13129/1828-6550/APMB.112.1.2024.CCS2
Refbacks
- There are currently no refbacks.
Copyright (c) 2024 Aurora Lanzafame, Tiziana Abbate, Giuseppina Zirilli, Flavia Caime, Domenico Corica, Malgorzata Wasniewska
This work is licensed under a Creative Commons Attribution 4.0 International License.